Scinopharm Taiwan Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Scinopharm Taiwan Limited with three other
companies in this sector in Taiwan:
Chunghwa Chemical Synthesis & Biotech Co Ltd
sales of 1.16 billion Taiwanese Dollars [US$37.00 million]
of which 56%
Sci Pharmtech Inc
(1.81 billion Taiwanese Dollars [US$57.65 million]
of which 100%
was Manufacture and Sale of Pharmaceutical), and
Panion & Bf Biotech Inc.
(1.21 billion Taiwanese Dollars [US$38.37 million]
of which 68%
During the year ended December of 2015, sales at
Scinopharm Taiwan Limited were 3.96 billion Taiwanese Dollars (US$125.93 million).
decrease of 3.5%
versus 2014, when the company's sales were 4.10 billion Taiwanese Dollars.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Scinopharm Taiwan Limited had sales
of 3.89 billion Taiwanese Dollars.
Contributing to the drop in overall sales was the 4.8% decline
in Taiwan Shenlong, from 4.09 billion Taiwanese Dollars to 3.90 billion Taiwanese Dollars.
However, these declines were partially offset by the increase in sales of
Other (up 982.4% to 58.07 million Taiwanese Dollars)